Partnerships with Federally Qualified Health Centers (FQHCs) provide opportunities to reduce costs and/or lower the incremental costs of training more residents while improving the quality of the training.
With shrinking clinical margins, AMCs are increasingly focused on ensuring institutional expenses and investments are tightly aligned with the organization’s clinical strategy. For AMCs to strategically manage their institutional investments, they must first understand the full extent of their expenditures, especially with regards to research.
In the final rule for the fiscal year 2019 update to the inpatient prospective payment system, effective August 17, 2018, CMS announced a new round of applications due to the closure of Memorial Hospital of Rhode Island. This is only the 13th round of section 5506 cap space reallocation since passage of the PPACA.
A robust, high-quality clinical or health service research program can be a significant differentiator for community hospitals and health systems. What are the research investments and research-related incentives for such a program?
Although the primary driver of reclassification is typically the positive impact on clinical payments, there can also be significant implications for the hospital’s graduate medical education reimbursement.
Facing revenue stream challenges, schools of medicine (SOMs) are evaluating the distribution and use of their limited resources and embracing more data-driven approaches to financing academic activities.
This article presents a simplified research strategy framework for AMCs to use to address their research enterprise priorities.
Determining the appropriate level and mix of nonphysician staff is a critical challenge when building and maintaining a high-performing trauma program.
Apple has a way of transforming entire industries. With ResearchKit, can the tech giant change the way researchers conduct clinical trials?
Page 1 of 3